| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.76B | +8.3% |
| Cost of Revenue | $4.86B | +6.9% |
| Gross Profit | $1.90B | +12.1% |
| R&D Expense | $111.0M | +1.8% |
| SG&A Expense | $1.14B | +18.5% |
| Operating Income | $520.0M | -4.9% |
| Pre-tax Income | $221.0M | -29.4% |
| Income Tax | $105.0M | +1.9% |
| Net Income | $116.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $692.0M | +8.8% |
| Accounts Receivable | $1.02B | +5.1% |
| Inventory | $1.24B | +31.5% |
| Current Assets | $3.17B | +15.6% |
| Total Assets | $8.20B | +23.4% |
| Current Liabilities | $1.79B | +17.4% |
| Long-term Debt | $2.02B | +42.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $444.0M | +0.9% |
| Capital Expenditures | $80.0M | -23.8% |
| Investing Cash Flow | -$1.41B | -3102.3% |
| Financing Cash Flow | $1.03B | +1710.9% |
| Free Cash Flow | $364.0M | +8.7% |
| -44.8% |
| EPS (Basic) | $0.62 | -56.6% |
| EPS (Diluted) | $0.61 | -57.0% |
| Total Liabilities |
| $4.89B |
| +25.5% |
| Stockholders' Equity | $3.31B | +20.4% |